logo
Wounded Palestinians dying over lack of supplies, US surgeon who worked in Gaza says

Wounded Palestinians dying over lack of supplies, US surgeon who worked in Gaza says

Yahoo30-03-2025

An American surgeon who's been working in two Gaza hospitals for the past three weeks has said that wounded Palestinian patients have died because of the lack of equipment and supplies.
Dr Mark Perlmutter says that doctors have had to work in operating rooms without soap, antibiotics or x-ray facilities, as Israel has resumed its offensive against Hamas in Gaza.
A 15-year-old girl who was hit by Israeli machine gun fire while riding her bicycle was one of the many wounded children that Dr Perlmutter said he had to operate on.
The Israeli government has said the renewed attacks that its military is carrying out in Gaza are aimed at forcing Hamas to release all the remaining hostages.
Dr Perlmutter spoke to the BBC shortly after the end of his second trip to Gaza - the first one was around a year ago. Critical of Israel's conduct in the Strip, he has previously called for an arms embargo and said its attacks on Gaza constitute genocide, which Israel vehemently denies.
This time, he worked in Al-Aqsa hospital in Deir al-Balah in the centre of the territory and then in Nasser hospital in the south of Gaza.
He has been working for Humanity Auxilium in Gaza as part of a wider World Health Organization (WHO) programme.
He was in Nasser hospital when it was hit by an Israeli air strike, targeting Ismail Barhoum, the Hamas finance chief.
Hamas said that Barhoum was being treated for injuries that he suffered in an earlier Israeli attack. The Israeli military denied this, saying he was in the hospital "in order to commit acts of terrorism".
Dr Perlmutter has told the BBC that Barhoum was in the hospital to receive further medical treatment. He says that as a patient in hospital, Barhoum had a right to be protected under the Geneva Convention.
The human cost of the latest Israeli offensive was exemplified for Dr Perlmutter by two 15-year-olds - including the girl on the bicycle - who were brought into the operating room in each of the hospitals he was working in, a week apart.
"They were both macerated and shredded by Apache gunships," Dr Perlmutter says.
The girl will, in his words, "be lucky if she keeps three of her limbs".
Dr Perlmutter says that people at the scene told the ambulance crew who brought the young girl into the hospital that she was hit by gunfire from an Israeli military helicopter.
He says that she had been riding her bicycle by herself and she arrived at the hospital without a backpack or anything else that might have aroused suspicion. Graphic images from the operating table show catastrophic wounds to her leg and arm.
The boy was driving in a car with his grandmother after receiving warnings to evacuate from the north, Dr Perlmutter says.
"Then the car was attacked by two Apache gunships. The grandmother was shredded at the scene and died," he said.
"The boy came in without a foot on his right side, the vascular repair on his left side took five hours - the nerve repair on his left side failed and he had a blackened hand the next day that required amputation at the level of his elbow - his left leg will require multiple surgeries for reconstruction and he has a chest wound. He may not have survived."
Dr Perlmutter has also provided graphic photos of the boy's wounds.
In a statement, the Israel Defense Forces (IDF) said it "does not target uninvolved individuals."
"The IDF operates in accordance with international law, targeting only military objectives while taking feasible measures to mitigate harm to civilians," it told the BBC.
The statement also said that the IDF had not been provided with "sufficient information" to directly address the incidents that Dr Perlmutter described.
"The IDF takes action to address irregular incidents that deviate from its orders. The IDF examines such incidents and takes appropriate measures where justified," it said.
Under such conditions, Dr Perlmutter stressed the commitment and dedication of the Palestinian medical staff - above and beyond the efforts of foreign doctors like himself.
"The stress levels on us are not even approachable to what happens even to the Palestinian medical students that work with us, whose stress levels are insane, as with the nurses and the techs in the operating room, let alone the Palestinian surgeons," he said.
"They all abandon their families, they volunteer and often work without pay. They work the same hours that we do - and we get to go home in a month, which they don't. They still have to return to the squalor of their tents where there's often 50 people living in a tent built for 20 - and sharing one toilet."
Most hospitals across Gaza are out of operation or barely managing to function. Dr Perlmutter compared the medical facilities in Gaza to where he lives in North Carolina. There are multiple trauma centres there, but they would have been overwhelmed, he says, if they had to deal with the mass influx of casualties that resulted from the first day of Israel's resumption of its war against Hamas.
"The small community hospital, Al-Aqsa, is a tenth the size of any of the facilities in my home state - maybe smaller - and it did well to manage those horrible injuries - nevertheless, because of lack of equipment, many, many of those patients died, who would certainly not have died at a better equipped hospital," he said.
On Saturday the UN's humanitarian chief Tom Fletcher described the current situation in Gaza as dire.
"All entry points into Gaza are closed for cargo since early March. At the border, food is rotting, medicine expiring and vital medical equipment is stuck," he said.
"If the basic principles of humanitarian law still count, the international community must act to uphold them."
On 2 March the Israeli government closed border crossings with Gaza and halted humanitarian aid. It said this was in response to what it called the refusal by Hamas of a new US proposal to extend the first stage of the ceasefire and hostage release deal, rather than negotiating a second phase.
"When Israel resumed its attacks, it was almost identical to when they bombed incessantly when I was here a year ago," Dr Perlmutter says. "The only difference is now instead of bombing people in buildings, they were bombing people in tents."
The Israeli army has regularly claimed that Hamas operates from areas where civilians are taking shelter. It says that it does not target civilians and takes measures to avoid civilian casualties.
The International Criminal Court last year issued arrest warrants for Israeli Prime Minister Benjamin Netanyahu and former defence minister Yoav Gallant over alleged war crimes, saying it found reasonable grounds to believe that "each bear criminal responsibility... for the war crime of intentionally directing an attack against the civilian population". They deny this.
Israeli attacks have killed more than 15,000 Palestinian children in Gaza, the Hamas-run health ministry has reported.
And since the IDF broke a ceasefire and resumed its strikes on 18 March, 921 Palestinians have been killed, the ministry said.
Dr Perlmutter warns that if there are more mass casualty events in Gaza from Israeli attacks, the lack of supplies in the two hospitals he's been working in means that more Palestinians will die from wounds that could have been treated.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

India brought forward its TB elimination deadline - but can it be met?
India brought forward its TB elimination deadline - but can it be met?

Yahoo

time32 minutes ago

  • Yahoo

India brought forward its TB elimination deadline - but can it be met?

Atul Kumar (name changed) anxiously paced the corridor of a public hospital in India's capital Delhi. A small-appliance mechanic, he was struggling to secure medicines for his 26-year-old daughter who suffers from drug-resistant tuberculosis (TB). Mr Kumar said his daughter needed 22 tablets of Monopas, an antibiotic used for treating TB, every day. "In the past 18 months, I haven't received government-supplied medicine for even two full months," he told BBC Hindi in January, months before India's declared deadline to eliminate the infectious disease. Forced to buy costly drugs from private pharmacies, Mr Kumar was drowning in debt. A week's supply cost 1,400 rupees ($16; £12), more than half his weekly income. After the BBC raised the issue, authorities supplied the medicines Mr Kumar's daughter needed. Federal Health Secretary Punya Salila Srivastava said that the government usually acts quickly to fix medicine access issues when alerted. Mr Kumar's daughter is one of millions of Indians suffering from tuberculosis, a bacterial disease that infects the lungs and is spread when the infected person coughs or sneezes. India, home to 27% of the world's tuberculosis cases, sees two TB-related deaths every three minutes. India's TB burden has long been tied to poor case detection, underfunding and erratic drug supply. Despite this grim reality, the country has set an ambitious goal. It aims to eliminate TB by the end of 2025, five years ahead of the global target set by the World Health Organization (WHO) and United Nations member states. Elimination, as defined by the WHO, means cutting new TB cases by 80% and deaths by 90% compared with 2015 levels. But visits to TB centres in Delhi and the eastern state of Odisha revealed troubling gaps in the government's TB programme. In Odisha's Khordha district, around 30km (18.6 miles) from state capital Bhubaneshwar, 32-year-old day-labourer Kanhucharan Sahu is struggling to continue his two-year-old daughter's TB treatment, with government medicines unavailable for three months and private ones costing 1,500 rupees a month - an unbearable burden. "We can't see her suffer anymore," he says, his voice breaking. "We even thought of abandoning her." At Odisha's local TB office, officials promised to review Sahu's case, but a staffer admitted, "We rarely get the medicines we need, so we ration them." Mr Sahu says he hasn't received the promised 1,000 rupees monthly support from the federal government and at the local TB office, officials admit to chronic shortages, leaving families like his adrift in a failing system. Vijayalakshmi Routray, who runs the patient support group Sahyog, says medicine shortages are now routine, with government outlets often running dry. "How can we talk about ending TB with such gaps?" she asks. There are other hurdles too - for example, changing treatment centres involves navigating complex bureaucracy, a barrier that often leads to missed doses and incomplete care. This poses a major hurdle for India's vast population of migrant workers. At a hospital near Khordha, 50-year-old Babu Nayak, a sweeper who was diagnosed with TB in 2023, struggles to continue his treatment. He was regularly forced to travel 100km to his village for medicines as officials insisted he collect them from the original centre where he was diagnosed and first treated. "It became too difficult," he says. Unable to travel so often, Mr Nayak stopped taking the medication altogether. "It was a mistake," he admitted, after contracting TB again last year and being hospitalised. At his hospital, no TB specialist was available, highlighting another critical gap in India's fight: a shortage of frontline health workers. The BBC shared its findings with the federal health ministry and officials in charge of the TB programme in Delhi and Odisha. There was no response despite repeated reminders. A 2023 parliamentary report showed there were many vacant roles across all levels of the TB programme, affecting diagnosis, treatment and follow-up - especially in rural and underserved areas. Can vaccines help India triumph over tuberculosis? In 2018, when Prime Minister Narendra Modi brought forward India's TB elimination target to 2025, he cited the government's intensified efforts as a reason for optimism. Two years later, the Covid pandemic disrupted TB elimination efforts globally, delaying diagnosis, diverting resources and pausing routine services. Medicine shortages, staff constraints and weakened patient monitoring have further widened the gap between ambition and reality. Despite these challenges, India has made some progress. Over the past decade, the country has reduced its tuberculosis-related mortality. Between 2015 and 2023, TB deaths declined from 28 to 22 per 100,000 people. This figure, however, is still high when compared with the global average which stands at 15.5. The number of reported cases has gone up, which the government credits to its targeted outreach and screening programmes. In 2024, India recorded 2.6 million TB cases, up from 2.5 million in 2023. Federal Health Minister JP Nadda recently touted innovations like handheld X-ray devices as game-changers in expanding testing. But on the ground, the picture is less optimistic. "I still see some patients come to me with reports of sputum (phlegm) smear microscopy for TB, a test which has a much lower detection rate as compared to genetic tests," says Dr Lancelot Pinto, a Mumbai-based epidemiologist. Genetic tests, which includes RT-PCR machines - widely used to diagnose HIV, influenza and most recently, Covid-19 - and Nucleic Acid Amplification Testing, also examine the sputum sample but with greater sensitivity and in a shorter timeframe. Besides, the tests can reveal whether the TB strain is drug-resistant or sensitive, something that microscopic testing can't do, Dr Pinto says. The gap, he adds, stems not just from lack of awareness but from limited access to modern tests. "Genetic testing is free at government hospitals but not uniformly available, with only a few states being able to provide it." In May, Modi led a high-level review of India's TB elimination programme, reaffirming the country's commitment to defeating the disease. But the official statement notably skipped mention of the 2025 deadline. Instead, it highlighted community-driven strategies - better sanitation, nutrition and social support for TB-affected families - as key to the fight. The government has also prioritised better diagnosis, treatment and prevention at the core of its elimination strategy. This approach mirrors the WHO's view of TB as a "disease of poverty". In its 2024 report, WHO chief Tedros Adhanom Ghebreyesus called it "the definitive disease of deprivation", noting how poverty, malnutrition and treatment costs trap patients in a vicious cycle. As India pushes toward its goal of eliminating the disease, deep health and social inequalities remain hurdles. With just six months left until India's self-imposed deadline, new complications have emerged. The fallout from US President Donald Trump's withdrawal from the WHO and suspension of USAID operations has raised concerns about future funding for global TB efforts. Since 1998, USAID has invested more than $140m to help diagnose and treat TB patients in India. However, India's federal health secretary insists there is "no budgetary problem" anticipated. Meanwhile, hope lies on the horizon. Sixteen TB vaccine candidates are currently in development across the world, with the WHO projecting potential availability within five years, pending successful trials.

There's one vice RFK Jr. isn't talking about
There's one vice RFK Jr. isn't talking about

Yahoo

time32 minutes ago

  • Yahoo

There's one vice RFK Jr. isn't talking about

Robert F. Kennedy Jr. has made it his mission to remind Americans that they need to get off the couch and lay off the junk food. But there's one vice he's not talking about: smoking. That's troubled anti-smoking activists, researchers who focus on the diseases tobacco causes and Democrats in Congress who point out that smoking, despite a marked decline in recent years, still leads to more preventable deaths than anything else. Even so, Kennedy didn't mention the health impacts of smoking once in last month's Make America Healthy Again report assessing the biggest threats to Americans' health. That marks a turning point from the priorities of public health officials going back decades, including the Biden administration's, which targeted smoking as part of a moonshot plan to halve cancer death rates. Anti-tobacco advocates fear deemphasizing the dangers of tobacco could slow or even halt progress in driving down smoking rates. 'Attempting to combat chronic disease without tobacco control is like attempting a triathlon without a bicycle,' said Brian King, whom Kennedy pushed out of his job as the Food and Drug Administration's top tobacco regulator in April. 'You're destined for failure before leaving the starting line.' Since President Donald Trump's inauguration, his health agencies appear to have shelved two moves King planned to combat smoking: banning the last remaining legal cigarette flavoring, menthol, and requiring companies to reduce the amount of nicotine in their products. Nicotine is what makes cigarettes addictive. But an HHS spokesperson said the department 'remains steadfast in its mission to protect and promote public health,' adding that the MAHA report is not an 'exhaustive inventory of every HHS program or public health challenge.' 'HHS agencies continue to carry out their responsibilities, including work on tobacco control, with the highest level of integrity and commitment to the American public,' the spokesperson said. A sustained public health campaign to educate Americans about smoking's risks over decades has driven a huge decrease in use. In the 1960s, more than 4 in 10 adults smoked cigarettes. Now it's fewer than 1 in 8. And the public health success among kids is even starker. Fewer than 1 in 26 now smoke cigarettes, according to an analysis of federal data. The negative health impacts of tobacco use are well-studied and vast. For years it has been the top preventable cause of death in the United States, contributing to cancer, heart disease and stroke. But when Sen. Dick Durbin (D-Ill.) quizzed Kennedy about that during a budget hearing last month, asking him to name the 'No. 1 cause of preventable death in America today,' Kennedy was stumped. 'I'm not sure what you're talking about,' he said. Kennedy's apparent lack of interest in combating smoking — the word 'tobacco' appears in the MAHA report only within the context of his concerns about food marketing while 'smoking' and 'cigarettes' are never mentioned — also suggests this Trump administration won't be like the first. Then, Trump's FDA commissioner, Scott Gottlieb, put the menthol ban and the limits on nicotine on the table, drawing applause from anti-smoking activists. Congress permitted the agency to make those moves in a 2009 law. That law banned flavorings except menthol — which is a cash cow for Marlboro cigarette maker Philip Morris, whose support helped get the law passed — but gave the FDA the power to decide whether to ban it. It also gave the agency the power to force cigarette companies to reduce nicotine levels. The Obama administration didn't do so. President Joe Biden proposed limiting nicotine levels after the 2024 election but never finalized the rule. A Biden plan to ban menthol cigarettes in 2022 was also not finalized. Menthol is popular among Black smokers, and some Democrats feared a ban could alienate crucial voters in a presidential election year. Jerome Adams, who was surgeon general during the first Trump term, said he wants Kennedy to prioritize the tobacco regulations laid out in Gottlieb's tobacco regulation plan — an effort he said would benefit youth and marginalized communities that are disproportionately impacted by menthol cigarettes. 'These proposed regulations align with the MAHA movement's focus on preventing chronic diseases,' Adams said. The tobacco industry spent heavily on Trump's 2024 campaign — and already has a lot to show for it. Trump pledged to 'save' vaping on his social media site, Truth Social, in September after meeting with Vapor Technology Association Executive Director Tony Abboud. The Trump administration pushed King — whom the tobacco industry had criticized for years — out of his job leading the FDA's Center for Tobacco Products. Job dismissals led by Trump's Department of Government Efficiency also gutted the CDC Office on Smoking and Health, which oversees federal smoking cessation programs and studies. The Trump administration also slashed funds the National Institutes of Health disburses to research facilities, which scientists say could imperil tobacco smoking studies. Asked about the industry's contributions to the Trump campaign, White House spokesperson Kush Desai wrote in an email, 'the only special interest guiding the Administration's decision-making is the best interest of the American people.' Tobacco-control advocates say Trump's early moves could undermine the country's progress diminishing smoking and the diseases it causes. 'These levels are decreasing because we have made such a commitment over the past few decades to enact things to work to get these levels down,' said Catharine Young, a Biden administration official who worked on his cancer moonshot initiative. 'But if you stop that or if you don't increase that effort, they're not going to continue to go down. They're either going to flat line, or they're going to start rising again.' Both Democratic and Republican administrations have hesitated to use all the regulatory authorities the 2009 law granted them. After Gottlieb resigned in March 2019, the agency's efforts to advance his 2017 tobacco plan were snuffed out. 'With his resignation, we lost the champion for the 2017 plan, and some months after he resigned, I was literally ordered by political appointees at FDA to stop talking publicly about menthol and nicotine,' said Mitch Zeller, who led the FDA's Center for Tobacco Products before King. Ultimately, Zeller wasn't able to implement a menthol ban or nicotine limits during any of the three administrations he served. During Biden's administration, then-FDA Commissioner Robert Califf enlisted allies outside the government to lobby the White House after agency efforts to ban menthol cigarettes were held up at the Office of Management and Budget. But the final rule was not published before Biden left office. 'They caved to political pressure from cigarette companies,' Zeller said. The FDA estimated the plan to limit nicotine levels in cigarettes proposed during the Biden administration would avert 4.3 million deaths and prevent 48 million youth and young adults from starting habitual cigarette smoking by the end of the century if implemented. And banning menthol cigarettes in the U.S. would cut 324,000 to 654,000 smoking-attributable deaths by 2060, according to modeling studies cited in the 2022 proposal. Luis Pinto, a spokesperson for Reynolds American, the maker of Lucky Strike, Camel and Newport cigarettes, said the company has not yet met with Trump's FDA commissioner, Marty Makary. Pinto said the company is opposed to a menthol cigarette ban because it believes there are "more effective and sustainable ways to help adult smokers transition away from combustible cigarettes." 'Rather than setting a nicotine standard, the focus should be on expanding access to a diverse and innovative portfolio of potentially reduced-risk products,' Pinto said. 'Tobacco harm reduction, not prohibition, is the most effective path forward in reducing the health impacts of smoking.' On Capitol Hill, Kennedy has rarely discussed tobacco despite his focus on preventing chronic disease, disappointing lawmakers like Durbin, the second ranking Democrat in the Senate. In an interview with POLITICO, Durbin emphasized the tobacco industry is still a threat to public health, especially as it markets more novel forms of nicotine exposure like vaping, which has become popular among younger Americans. 'The tobacco companies have not given up. Their basic approach is to addict children to their product, and so now they're using vaping and [other] devices to get … high schoolers in America addicted to forms of nicotine,' Durbin said, referring to Gottlieb as a hero. 'I just don't think you can credibly say you're addressing public health in America and ignore tobacco and vaping.' King, who's now with the Campaign for Tobacco-Free Kids, an anti-smoking group, is still hoping to convince Trump officials that going after tobacco needs to be part of the MAHA agenda. And he says he sees hope in the FDA's crackdown on illegal e-cigarettes, which he interprets as a sign the government is looking to snuff out unapproved vaping products. 'We have seen the decimation of tobacco control infrastructure,' King said. 'It's important you have the resources and the people.'

There's one vice RFK Jr. isn't talking about
There's one vice RFK Jr. isn't talking about

Politico

time2 hours ago

  • Politico

There's one vice RFK Jr. isn't talking about

Robert F. Kennedy Jr. has made it his mission to remind Americans that they need to get off the couch and lay off the junk food. But there's one vice he's not talking about: smoking. That's troubled anti-smoking activists, researchers who focus on the diseases tobacco causes and Democrats in Congress who point out that smoking, despite a marked decline in recent years, still leads to more preventable deaths than anything else. Even so, Kennedy didn't mention the health impacts of smoking once in last month's Make America Healthy Again report assessing the biggest threats to Americans' health. That marks a turning point from the priorities of public health officials going back decades, including the Biden administration's, which targeted smoking as part of a moonshot plan to halve cancer death rates. Anti-tobacco advocates fear deemphasizing the dangers of tobacco could slow or even halt progress in driving down smoking rates. 'Attempting to combat chronic disease without tobacco control is like attempting a triathlon without a bicycle,' said Brian King, whom Kennedy pushed out of his job as the Food and Drug Administration's top tobacco regulator in April. 'You're destined for failure before leaving the starting line.' Since President Donald Trump's inauguration, his health agencies appear to have shelved two moves King planned to combat smoking, banning the last remaining legal cigarette flavoring, menthol, and requiring companies to reduce the amount of nicotine in their products. Nicotine is what makes cigarettes addictive. But an HHS spokesperson said the department 'remains steadfast in its mission to protect and promote public health,' adding that the MAHA report is not an 'exhaustive inventory of every HHS program or public health challenge.' 'HHS agencies continue to carry out their responsibilities, including work on tobacco control, with the highest level of integrity and commitment to the American public,' the spokesperson said. A sustained public health campaign to educate Americans about smoking's risks over decades has driven a huge decrease in use. In the 1960s, more than 4 in 10 adults smoked cigarettes. Now it's fewer than 1 in 8. And the public health success among kids is even starker. Fewer than 1 in 26 now smoke cigarettes, according to an analysis of federal data. The negative health impacts of tobacco use are well-studied and vast. For years it has been the top preventable cause of death in the United States, contributing to cancer, heart disease and stroke. But when Sen. Dick Durbin (D-Ill.) quizzed Kennedy about that during a budget hearing last month, asking him to name the 'No. 1 cause of preventable death in America today,' Kennedy was stumped. 'I'm not sure what you're talking about,' he said. Kennedy's apparent lack of interest in combating smoking — the word 'tobacco' appears in the MAHA report only within the context of his concerns about food marketing while 'smoking' and 'cigarettes' are never mentioned — also suggests this Trump administration won't be like the first. Then, Trump's FDA commissioner, Scott Gottlieb, put the menthol ban and the limits on nicotine on the table, drawing applause from anti-smoking activists. Congress permitted the agency to make those moves in a 2009 law. That law banned flavorings except menthol — which is a cash cow for Marlboro cigarette maker Philip Morris, whose support helped get the law passed — but gave the FDA the power to decide whether to ban it. It also gave the agency the power to force cigarette companies to reduce nicotine levels. The Obama administration didn't do so. President Joe Biden proposed limiting nicotine levels after the 2024 election but never finalized the rule. A Biden plan to ban menthol cigarettes in 2022 was also not finalized. Menthol is popular among Black smokers and some Democrats feared a ban could alienate crucial voters in a presidential election year. Jerome Adams, who was surgeon general during the first Trump term, said he wants Kennedy to prioritize the tobacco regulations laid out in Gottlieb's tobacco regulation plan — an effort he said would benefit youth and marginalized communities that are disproportionately impacted by menthol cigarettes. 'These proposed regulations align with the MAHA movement's focus on preventing chronic diseases,' Adams said. The tobacco industry spent heavily on Trump's 2024 campaign — and already has a lot to show for it. Trump pledged to 'save' vaping on his social media site, Truth Social, in September after meeting with Vapor Technology Association Executive Director Tony Abboud. The Trump administration pushed King — whom the tobacco industry had criticized for years — out of his job leading the FDA's Center for Tobacco Products. Job dismissals led by Trump's Department of Government Efficiency also gutted the CDC Office on Smoking and Health, which oversees federal smoking cessation programs and studies. The Trump administration also slashed funds the National Institutes of Health disburses to research facilities, which scientists say could imperil tobacco smoking studies. Asked about the industry's contributions to the Trump campaign, White House spokesperson Kush Desai wrote in an email, 'the only special interest guiding the Administration's decision-making is the best interest of the American people.' Tobacco-control advocates say Trump's early moves could undermine the country's progress diminishing smoking and the diseases it causes. 'These levels are decreasing because we have made such a commitment over the past few decades to enact things to work to get these levels down,' said Catharine Young, a Biden administration official who worked on his cancer moonshot initiative. 'But if you stop that or if you don't increase that effort, they're not going to continue to go down. They're either going to flat line, or they're going to start rising again.' Both Democratic and Republican administrations have hesitated to use all the regulatory authorities the 2009 law granted them. After Gottlieb resigned in March 2019, the agency's efforts to advance his 2017 tobacco plan were snuffed out. 'With his resignation, we lost the champion for the 2017 plan, and some months after he resigned, I was literally ordered by political appointees at FDA to stop talking publicly about menthol and nicotine,' said Mitch Zeller, who led the FDA's Center for Tobacco Products before King. Ultimately, Zeller wasn't able to implement a menthol ban or nicotine limits during any of the three administrations he served. During Biden's administration, then-FDA Commissioner Robert Califf enlisted allies outside the government to lobby the White House after agency efforts to ban menthol cigarettes were held up at the Office of Management and Budget. But the final rule was not published before Biden left office. 'They caved to political pressure from cigarette companies,' Zeller said. The FDA estimated the plan to limit nicotine levels in cigarettes proposed during the Biden administration would avert 4.3 million deaths and prevent 48 million youth and young adults from starting habitual cigarette smoking by the end of the century if implemented. And banning menthol cigarettes in the U.S. would cut 324,000 to 654,000 smoking-attributable deaths by 2060, according to modeling studies cited in the 2022 proposal. Luis Pinto, a spokesperson for Reynolds American, the maker of Lucky Strike, Camel and Newport cigarettes, said the company has not yet met with Trump's FDA commissioner, Marty Makary. Pinto said the company is opposed to a menthol cigarette ban because it believes there are 'more effective and sustainable ways to help adult smokers transition away from combustible cigarettes.' 'Rather than setting a nicotine standard, the focus should be on expanding access to a diverse and innovative portfolio of potentially reduced-risk products,' Pinto said. 'Tobacco harm reduction, not prohibition, is the most effective path forward in reducing the health impacts of smoking.' On Capitol Hill, Kennedy has rarely discussed tobacco despite his focus on preventing chronic disease, disappointing lawmakers like Durbin, the second ranking Democrat in the Senate. In an interview with POLITICO, Durbin emphasized the tobacco industry is still a threat to public health, especially as it markets more novel forms of nicotine exposure like vaping, which has become popular among younger Americans. 'The tobacco companies have not given up. Their basic approach is to addict children to their product, and so now they're using vaping and [other] devices to get … high schoolers in America addicted to forms of nicotine,' Durbin said, referring to Gottlieb as a hero. 'I just don't think you can credibly say you're addressing public health in America and ignore tobacco and vaping.' King, who's now with the Campaign for Tobacco-Free Kids, an anti-smoking group, is still hoping to convince Trump officials that going after tobacco needs to be part of the MAHA agenda. And he says he sees hope in the FDA's crackdown on illegal e-cigarettes, which he interprets as a sign the government is looking to snuff out unapproved vaping products. 'We have seen the decimation of tobacco control infrastructure,' King said. 'It's important you have the resources and the people.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store